Takeda: Dengue Vaccine Candidate Works Without Big Safety Risks

Takeda's TAK-003 dengue vaccine showed long-term efficacy and no antibody-dependent enhancement reactions in seronegative patients. It can be given without prior serologic testing.
Medscape Medical News